Parasites and diarrhea. I: Protozoans and diarrhea

Journal of Travel Medicine

Volumn 4, Issue 1, 1997, Pages 17-31

  Hashmey, Rayhan ^a   Genta, Robert M ^a   White Jr , A Clinton ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANTIDIUM; BLASTOCYSTIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; GIARDIASIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROSPORIDIOSIS; PARASITISM; PATHOGENESIS; PREVALENCE; REVIEW;

EID: 0030992228     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1708-8305.1997.tb00769.x     Document Type: Review

References (185)

1. Soltys D, Gupta R. Immunoelectron microscopy of Giardia lamblia cytoskeleton using antibody to acetylated alpha-tubulin. J Eukar Microbiol 1994;41(6):625-632.
2. Chavez B, Martinezpalomo A. Giardia lamblia: freeze fracture structure of the ventral disc plasma membrane. J Eukar Microbiol 1995;42:136-141.
3. Farthing M. Diarrheal disease: current concepts and future challenges. Pathogenesis of giardiasis. Trans R Soc Trop Med Hyg 1993;87:17-21.
4. Gilman R, Brown K. Epidemiology and serology of Giardia lamblia in a developing country: Bangladesh 1985.Trans R Soc Trop Med Hyg 1985;79:469-473.
5. Kappus KD, Lundgen RJ, Juranek D, et al. Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg 1994;50:705-713.
6. Hill D. Giardiasis: issues in diagnosis and management. Infect Dis Clin North Am 1994;7(3):503-525.
7. Craun G. Waterborne giardiasis in the United States. Lancet 1986;2:513-514.
8. Kelsall DL, Guerrant RL. Evaluation of diarrhea in the returning traveler. Infect Dis Clin North Am 1992;6:413-425.
9. Brodsky R, Spencer HJ, Schultz M. Giardiasis in American travelers to the Soviet Union.J Infect Dis 1974;130:319.
10. Steffan R, Richenback M, Wilhem U. Health problems after travel to developing countries. J Infect Dis 1987;156:84-91.
11. Gray SF, Rouse AR. Giardiasis - a cause of travellers' diarrhoea. CDR Review 1992;2:R45-47.
12. Mintz ED, Hudson-Wragg M, Mshar P, et al. Foodborne giardiasis in a corporate office setting. J Infect Dis 1993; 167:250-253.
13. Quick R, Paugh K, Addiss D, et al. Restaurant-associated outbreak of giardiasis. J Infect Dis 1992; 166:673-676.
14. Porter JD, Gaffney C, Heymann D, et al. Food-borne outbreak of Giardia lamblia. Am J Public Health 1990;80:1259-1260.
15. Pickering L, Woodward W, DuPont H. Occurrence of Giardia lamblia in children in day care centers. J Pediatr 1984; 104:522-526.
16. Dykes A, Duranek D. Municipal waterborne giardiasis: an epidemiological investigation. Beavers implicated as a possible reservoir. Ann Intern Med 1978;92:165-170.
17. Balasz M, Szaltocky E. Electron microscopic examination of the mucosa of the small intestine in infection due to Giardia lamblia. Path Res Pract 1978;163:250-260.
18. Owen R, Nemanic P, Stevens D. Ultrastructural observations of giardiasis in a murine model. Intestinal distribution, attachment and relationship to the immune system of Giardia muris. Gastroenterol 1979;76:757-769.
19. Nash T, Keister D. Differences in excretory-secretory products and surface antigens among 19 isolates of Giardia. J Infect Dis 1985;152:1166-1171.
20. Meloni DP, Lymbery AJ, Thompson RCA. Genetic characteristics of isolates of Giardia duodenalis by enzyme electrophoresis: implications for reproductive biology, population structure, taxonomy and epidemiology. J Parasitol 1995; 81:368-383.
21. Heyworth M. Immunology of Giardia and Cryptosporidinm infections. J Infect Dis 1992;166:465-472.
22. Hill D. Giardia lamblia. In: Mandell G, ed. Principles and practice of infectious diseases. Vol. 2. New York: Churchill Livingstone, 1995:2487-2493.
23. Shaw R, Stevens M. The reactive arthritis of giardiasis. JAMA 1987;258:2734.
24. Adam R. The biology of Giardia spp. Microbiol Rev 1991;55:706-722.
25. Hiatt RA, Markell EK, Ng E. How many stool examinations are necessary to detect pathogenic intestinal protozoa. Am J Trop Med Hyg 1995;53:36-39.
26. Aldeen WE, Hale D, Robison AJ, et al. Evaluation of a commercially available ELISA assay for detection of Giardia lamblia in fecal specimens. Diagn Microbiol Infect Dis 1995:21:77-79.
27. Cordts B, Hemehof W, Asselman C. In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to SLX commonly used antiprotozoal agents. Antimicrob Agents Chemother 1985:28:378-380.
28. Speelman P. Single doseTinidazole for the treatment of giardiasis. Antimicrob Agents Chemother 1985;27:227-229.
29. Gilman R, Marquis G, et al. Rapid reinfection by Giardia lamblia after treatment in a hyperendemic third world community. Lancet 1988;1:343-345.
30. Black RE, Dykes AC, Anderson KE, et al. Handwashing to prevent diarrhea in day-care centers. Am J Epidemiol 1981;113:445-451.
31. Reeves RE, Bischkoff JM. Classification of Entameba species by means of electrophoretic properties of amebal enzymes. J Parasitol 1968;54:594-600.
32. Mathews H, Moss D, Healy G. Polyacrylamide gel electrophoresis of isozymes of Entamoeba species. J Clin Microbiol 1983;17:1009-1012.
33. Tammich E, Horstmann R. Genomic DNA differences between padiogenic and non-pathogenic strains of E. histolytica. Proc Nat Acad Sci USA 1989;86:5118-5122.
34. Proctor E. Laboratory diagnosis of amebiasis. Clin Lab Med 1991;11(4):829-859.
35. Ravdin JI. Amebiasis. Clin Infect Dis 1995;20:1453-1464.
36. Ravdin J, ed. Amebiasis: human infection by E. histolytica. New York: Wiley, 1988.
37. Irusen E, Jackson T, Simjee A. Asymptomatic intestinal colonization by pathogenic E. histolytica in amebic liver abscess: prevalence, response to therapy and pathogenic potential. Clin Infect Dis 1990;14:889-893.
38. Aucott J, Ravdin J. Amebiasis and "non-pathogenic" intestinal protozoa. Infect Dis Clin North Am 1993;7(3):467-485.
39. Braga L, Ninimiya H, McCoy J. Inhibition of complement attack membrane complex by galactose specific adhesion of E. histolytica. J Clin Invest 1992;90:1131-1137.
40. Ravdin J, Moreau F, Sullivan J.The relationship of free intracellular calcium ions to the cytolytic activity of E. histolytica. Infect Immun 1988;56:1502-1512.
41. McKerrow J, Sun E, Rosenthal P, et al. The proteases and pathogenicity of parasitic protozoa. Ann Rev Microbiol 1993;47:821-853.
42. Stanley SL, ZhangTH, Rubin D, et al. Role of the Entamoeba histolytica cysteine proteinase in amebic liver abscess formation in severe combined immunodeficient mice. Infect Immun 1995;63:1587-1590.
43. Prathap K, Gilman R. The histopathology of acute intestinal amebiasis. Am J Pathol 1970;60:229-239.
44. Ahmed M, McAdam K, Strum A, et al. Systemic manifestations of invasive amebiasis. Clin Infect Dis 1991;15:974-982.
45. Gonzales-Ruiz A, Haque R. Value of microscopy in the diagnosis of dysentery by E. histolytica. J Clin Pathol 1994;47: 236-239.
46. Healy G. Diagnostic techniques for stool samples. In: Ravdin J, ed. Amebiasis: human infection by E. histolytica. Vol. 1. New York:Wiley,1988.
47. Haque R, Neville LM, Hahn P, et al. Rapid diagnosis of Entamoeba infection by using Entamoeba and Entamoeba histolytica stool antigen detection kits. J Clin Microbiol 1995;33: 2558-2561.
48. Cooperstock M, DuPont H, Corrado M, et al. Evaluation of new anti-infective drugs for the treatment of diarrhea caused by E. histolytica. Clin Infect Dis 1991;15:S254-S258.
49. Khaw M, Panosian C. Human antiprotozoal therapy: past, present and future. Clin Microbiol Rev 1995;8:427-439.
50. Simjee A, Gaithiram V, Jackson T, et al. A comparative trial of metronidazole vs. tinidazole in the treatment of amebic liver disease.S Afr Med J 1985;68:923.
51. Fayer R, Speer CA, Dubey JP. General biology of Cryptosporidinm. In: Dubey JP, Speer CA, Fayer R, eds. Cryptosporidiosis of man and animals. Boca Raton, FL: CRC Press, 1990:1-29.
52. Fayer R, Ungar BLP. Cryptosporidium spp. and cryptosporidiosis. Microbiol Rev 1986;50:458-483.
53. Ungar BLP. Cryptosporidiosis in humans (Homo sapiens). In: Dubey JP, Speer CA, Fayer R, eds. Cryptosporidiosis of man and animals. Boca Raton, FL: CRC Press, 1990:59-82.
54. Soave R, Ruiz J, Garcia-Saucedo V, et al. Cryptosporidiosis in a rural community in central Mexico. J Infect Dis 1989;159: 1160-1163.
55. Ungar BLP, Gilman RH, Lanata CF, et al. Seroepidemiology of Cryptosporidium infection in two Latin American populations. J Infect Dis 1988;157:551-556.
56. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991;4:325-358.
57. Addy PAK, Aikins-Bekoe P. Cryptosporidiosis in diarrheal children in Kumasi, Ghana. Lancet 1986;1:735.
58. Bogaerts J, Lepage P, Rouvony D, et al. Cryptosporidium species, a frequent cause of diarrhoea in Central Africa. J Clin Microbiol 1984;20:874-876.
59. Mata L, Bolanos H, Pizarro D, et al. Cryptosporidiosis in children from some highland Costa Rican rural and urban areas. Am J Trop Med Hyg 1984;33:24-29.
60. Mathan MM, Venkatesan S, George R, et al. Cryptosporidiosis and diarrhoea in southern Indian children. Lancet 1985;2:1172-1175.
61. Pape JW, Levine E, Beaulieu ME, et al. Cryptosporidiosis in Haitian children. Am J Trop Med Hyg 1987;36:333-337.
62. Shahid NS, Rahman ASMH, Anderson BC, et al. Cryptosporidiosis in Bangladesh. BMJ 1985;290:114-115.
63. Weikel CS, Johnston L, DeSousa A, et al. Cryptosporidiosis in northeastern Brazil. J Infect Dis 1985;151:963-965.
64. Wolfson JS, Richter JM, Waldron MA, et al. Cryptosporidiosis in immunocompetent hosts. N Engl J Med 1985;312: 1278-1282.
65. Soave R, Ma P. Cryptosporidiosis. Traveler's diarrhea in two families. Arch Intern Med 1985;145:70-72.
66. Ma P, Kaufman DL, Helmick CG, et al. Cryptosporidiosis in tourists returning from the Caribbean. N Engl J Med 1985;312:647-648.
67. Jokipii L, Pohjola S, Jokipii AMM. Cryptosporidium: a frequent finding in patients with gastrointestinal symptoms. Lancet 1983;2:358-361.
68. Juranek DD. Cryptosporidiosis - sources of infection and guidelines for prevention. Clin Infect Dis 1995;21:S57-S61.
69. Smith HV, Patterson WJ, Hardie R, et al. An outbreak of water-borne cryptosporidiosis caused by post-treatment contamination. Epidemiol Infect 1989;103:703-715.
70. Hayes EB, Matte TD, O'Brien TR, et al. Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N Engl J Med 1989;320:1372-1376.
71. D'Antonio RG, Win RE, Taylor JP, et al. A waterborne outbreak of cryptosporidiosis in normal hosts. Ann Intern Med 1986;103:886-888.
72. MacKenzie WR, Schell WL, Blair KA, et al. Massive outbreak of waterborne Cryptosporidium infection in Milwaukee, WI: recurrence of illness and risk of secondary transmission. Clin Infect Dis 1995;21:57-62.
73. Mackenzie WR, Addiss DG, Davis JP. Cryptosporidium and the public water supply - reply. N Engl J Med 1994;331:1530.
74. Current WL, Reese NC, Ernst JV, et al. Human cryptosporidiosis in immunocompetent and immunodeficient persons: studies of an outbreak and experimental transmission. N Engl J Med 1983;308:1252-1257.
75. MacKenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994;331:161-167.
76. Anonymous. Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. Public Health Laboratory Service Study Group. BMJ 1990;300:774-777.
77. Alpert G, Bell LM, Kirkpatrick CE, et al. Outbreak of cryptosporidiosis in a day-care center. Pediatrics 1986;77:152-157.
78. Anonymous. Cryptosporidiosis among children attending day-care centers - Georgia, Pennsylvania, Michigan, California, New Mexico. MMWR 1984;33:599-601.
79. Koch KL, Phillips DJ, Aber RC, et al. Cryptosporidiosis in hospital personnel: evidence for person-to-person transmission. Ann Intern Med 1984;102:593-596.
80. Soave R, Danner RL, Honig CL, et al. Cryptosporidiosis in homosexual males. Ann Intern Med 1984;100:504-511.
81. Jokipii L, Pohjola S, Jokipii AM. Cryptosporidiosis associated with traveling and giardiasis. Gastroenterol 1985;89:838-842.
82. Ungar BL, Mulligan M, Nutman TB. Serologic evidence of Cryptosporidium infection in US volunteers before and during Peace Corps service in Africa. Arch Intern Med 1989;149:894-897.
83. Navin TR, Hardy AM. Cryptosporidiosis in patients with AIDS. J Infect Dis 1987;155:150.
84. Sewankambo N, Mugerwa RD, Goodgame R, et al. Enteropathic AIDS in Uganda: an endoscopic, histologic, and microbiologic study. AIDS 1987;1:9-13.
85. Sanchez-Mejorada G, Ponce-de-Leon S, Vilarcompte D, et al. AIDS in Mexico 1983-1990: changing clinical trends. 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 1991.
86. Diaz RMDS, Mangini ACS, Torres DMAGV, et al. Cryptosporidiosis among patients with acquired immunodeficiency syndrome (AIDS) in the county of São Paulo, Brazil. Rev Inst Med Trop Sao Paulo 1988;30:310-312.
87. Current WL. Cryptosporidium spp. In: Walzer PD, Genta RM, eds. Parasitic infections in the compromised host. New York: Marcel Dekker, Inc., 1989:281-341.
88. Genta RM, Chappell CL, White AC Jr, et al. Duodenal morphology and intensity of infection in AIDS-related cryptosporidiosis. Gastroenterol 1993;105:1769-1775.
89. Goodgame RW, Kimball K, Ou CN, et al. Intestinal function and injury in AIDS-related cryptosporidiosis. Gastroenterol 1995;108:1075-1082.
90. Martins CAP, Guerrant RL. Cryptosporidium and cryptosporidiosis. Parasitol Today 1995;11:434-436.
91. Guarino A, Canani RB, Casola A, et al. Human intestinal cryptosporidiosis: secretory diarrhea and enterotoxic activity in Caco-2 cells. J Infect Dis 1995;171:976-983.
92. Flanigan TP. Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses. Am J Trop Med Hyg 1994;50:29-35.
93. Benhamou Y, Kapel N, Hoang C, et al. Inefficacy of intestinal secretory immune response to Cryptosporidium in the Acquired Immunodeficiency Syndrome. Gastroenterol 1995;108:627-635.
94. Flanigan TP, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 count. Ann Intern Med 1992;116:840-842.
95. Ungar BLP, Kao T-C, Burris JA, et al. Cryptosporidium infection in an adult mouse model. Independant roles for IFN-g and CD4+T lymphocytes in protective immunity. J Immunol 1991;147:1014-1022.
96. Chen W, Harp JA, Harmsen AG. Requirement for CD4+ cells and gamma interferon in resolution of established Cryptosporidium parvum infection in mice. Infect Immun 1993;61: 3928-3932.
97. Dupont HL, Chappell CL, Sterling CR, et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995;332:855-859.
98. Jokipii L, Jokikii AMM. Timing of symptoms and oocyst exaction in human cryptosporidiosis. N Engl J Med 1986;315: 1643-1647.
99. Egger M, Mäusezahl D, Odermatt P, et al. Symptoms and transmission of intestinal cryptosporidiosis. Arch Dis Child 1990;65:445-447.
100. Soave R. Cryptosporidiosis and isosporiasis in patients with AIDS. Infect Dis Clin North Am 1988;2:485-493.
101. Fang GD, Lima AAM, Martins CV, et al. Etiology and epidemiology of persistent diarrhea in Northeastern Brazil: a hospital-based, prospective, case-controlled study. J Pediatr Gastroenterol Nutr 1995;21:137-144.
102. Roberts WG, Green PHR, Ma J, et al. Prevalence of cryptosporidiosis in patients undergoing endoscopy: evidence for an asymptomatic carrier state. Am J Med 1989;87:537-539.
103. Garcia LS, Current WL. Cryptosporidiosis: clinical features and diagnosis. Crit Rev Clin Lab Sci 1989;6:439-460.
104. Current WL.Techniques in laboratory maintenance of Cryptosporidium. In: Dubey JP, Speer CA, Fayer R, eds. Cryptosporidiosis of man and animals. Boca Raton, FL: CRC Press, 1990:31-49.
105. Zimmerman S, Needham C. Comparison of conventional stool concentration and preserved smear methods with Meriflour Cryptosporidium/ Giardia direct immunofluorescence assay and Prospect Giardia EZ microplate assay for detection of Giardia lambia. J Clin Microbiol 1995;33:1942-1943.
106. Garcia LS, Brewer TC, Bruckner DA. Fluorescence detection of Cryptosporidium oocysts in human fecal specimens by using monoclonal antibodies. J Clin Microbiol 1987;25:119-121.
107. Arrowood MJ, Sterling CR. Comparison of conventional staining methods and monoclonal antibody-based methods for Cryptosporidium oocyst detection. J Clin Microbiol 1989;27: 1490-1495.
108. Kotler DP, Francisco A, Clayton F, et al. Small intestinal injury and parasitic diseases in AIDS. Ann Intern Med 1990;113: 444-449.
109. Sallon S, Deckelbaum RJ, Schmid II, et al. Cryptosporidium, malnutrition, and chronic diarrhea. Am J Dis Child 1988; 142:312-315.
110. Simon DM, Cello JP, Valenzuela J. Multicenter trial of octreotide in patients with refractory Acquired Immunodeficiency Syndrome-associated diarrhea. Gastroenterol 1995; 108:1753-1760.
111. Portnoy D, Whiteside ME, Buckley E, et al. Treatment of intestinal cryptosporidiosis with spiramycin. Ann Intern Med 1984;101:202-204.
112. Soave R, Armstrong D. Cryptosporidium and cryptosporidiosis. Rev Infect Dis 1986;8:1012-1023.
113. Gathe J, Piot D, Hawkins K, et al. Treatment of gastrointestinal cryptosporidiosis with paromomycin. VIth Annual Conference on AIDS, San Francisco, 1990. Vol. 2. London:Welcome Foundation, 1990.
114. Marshall RJ, Flanigan TP. Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line. J Infect Dis 1992;165:772-774.
115. White AC Jr, Chappell CL, Hayat CS, et al. Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial. J Infect Dis 1994;170:419-424.
116. Brandborg LL, Goldberg SB, Briedenbach WC. Human coccidia - a possible cause of malabsorption. The life cycle in small-bowel mucosal biopsies as a diagnostic feature. N Engl J Med 1970;283:1306-1313.
117. Faust EC, Giraldo LE, Caidedo G, et al. Human isosporiasis in the western hemisphere. Am J Trop Med Hyg 1961;10: 343-349.
118. Smitskamp H, Dey-Muller E. Geographic distribution and clinical significance of human coccidiosis. Trop Geogr Med 1966;18:133-136.
119. Sorvillo FJ, Lieb LE, Seidel J, et al. Epidemiology of isosporiasis among persons with Acquired Immunodeficiency Syndrome in Los Angeles County. Am J Trop Med Hyg 1995;53: 656-659.
120. DeHovitz JA, Pape JW, Boncy M, et al. Clinical manifestations and therapy of Isospora belli infection in patients with the Acquired Immunodeficiency Syndrome. N Engl J Med 1986;315:87-90.
121. Trier JS, Moxey PC, Schimmel EM, et al. Chronic intestinal coccidiosis in man: intestinal morphology and response to treatment. Gastroenterol 1974;66:923-935.
122. Barksdale WL, Routh CF. Isospora hominis infections among American personnel in the southwest Pacific. Am J Trop Med 1948;28:639-644.
123. Henderson HE, Gillespie GW, Kaplan P, et al. The human hospora. Am J Hyg 1963;78:302-309.
124. Jarpa Gana A. Coccidiosis humana. Biologica (Santiago) 1966;39:3-26.
125. Matsubayashi H, Nozawa T. Experimental infection of Isospora hominis in man. Am J Trop Med 1948;28:633-637.
126. Sorvillo F, Lieb L, Iwakoshi. Isospora belli and the Acquired Immune Deficiency Syndrome. N Engl J Med 1990;322:131.
127. Benator D, French A, Beaudet L, et al. Cyclospora infection associated with cholecystitis in a patient with AIDS. Ann Intern Med 1994;121:663-664.
128. Alfandari S, Ajana F, Senneville E, et al. Haemorrhagic ulcerative colitis due to Isospora belli in AIDS. Int J STD AIDS 1995;6:216.
129. Ng E, Markell EK, Fleming RL, et al. Demonstration of Isospora belli by acid-fast stain in a patient with Acquired Immunodeficiency Syndrome. J Clin Microbiol 1984;20: 384-386.
130. Pape JW, Verdier R-I, Johnson WD Jr. Treatment and prophylaxis of Isospora belli infection in patients with the Acquired Immunodeficiency Syndrome. N Engl J Med 1989;320: 1044-1047.
131. Westerman EL, Christensen RP. Chronic Isospora belli infection treated with co-trimoxazole. Ann Intern Med 1979;91: 413-414.
132. Himy R, Villard O, Kremer M. Cyclosporidia: a review. J Travel Med 1993;2:33-36.
133. Pollock R, Bendall R, Moody A. Traveler's diarrhea associated with cyanobacterium like bodies. Lancet 1992;341: 556-557.
134. Bendall R, Lucas S, Moody A. Diarrhea associated with cyanobacterium like bodies: a new coccidian enteritis of man. Lancet 1993;341:590-592.
135. Ortega Y, Sterling C, Gilman R. Cyclospora species: a new protozoal pathogen of humans. N Engl J Med 1993;328: 1308-1312.
136. Ortega YR, Gilman RH, Sterling CR. A new coccidian parasite (Apicomplexa: Eimeriidae) from humans. J Parasitol 1994;80:625-629.
137. Pape W, Verdier R, Boncy M. Cyclospora infections in adults infected with HIV. Clinical manifestations, treatment and prophylaxis. Ann Intern Med 1994;121:654-657.
138. Hope C, Shlim D, Rajah R. Epidemiology of diarrheal illness associated with a coccidian like organism among travellers and foreign residents in Nepal. Lancet 1993;341: 1175-1179.
139. Gascon J, Corachan M, Dombi JA, et al. Cyclospora in patients with travellers diarrhea. Scand J Infect Dis 1995;27:511-514.
140. Anonymous. Outbreaks of diarrheal illness associated with Cyanobacteria (blue-green algae)-like bodies - Chicago and Nepal, 1989 and 1990. MMWR 1991;40:325-327.
141. Huang P, Weber JT, Sosin DM, et al. The first reported outbreak of diarrheal illness associated with Cyclospora in the United States. Ann Intern Med 1995;123:409-414.
142. Conner B, Shlim D, Scholes V. Pathologic changes in small bowel in nine patients with diarrhea associated with a coccidia like body. Ann Intern Med 1993;119:377-382.
143. Sifuentesosornio J, Porrascortes G, Bendall RP, et al. Cyclospora cayetanensis infection in patients with and without AIDS - biliary disease as another clinical manifestation. Clin Infect Dis 1995;21:1092-1097.
144. Long EG, White EH, Carmichael WW, et al. Morphologic and staining characteristics of a cyanobacterium-like organism associated with diarrhea. J Infect Dis 1991;164:199-202.
145. Topazian M, Bia F. New parasites around the block: emerging intestinal protozoa. Gastroenterol 1994;2:147-159.
146. Madico G, Gilman R, Miranda E. Treatment of Cyclospora infections with cotrimoxazole. Lancet 1993;342:122-123.
147. Hoge CW, Shlim DR, Ghimire M, et al. Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal. Lancet 1995;345: 691-693.
148. Bryan RT. Microsporidia. In: Mandell G, Benett J, Dolin R, eds. Principles and practice of infectious diseases. Vol. 2. New York: Churchill Livingstone, 1995.
149. Weber R, Bryan RT, Schwartz DA, et al. Human microsporidial infections. Clin Microbiol Rev 1994;7: 426-461.
150. Canning E, Hollister W. Human infections with Microsporidia. Rev Med Microbiol 1992;3:35-42.
151. Vossbrinck C, Barker M, Didier C, et al. Ribosomal RNA sequence suggests microsporidia are extremely primitive eukaryotes. Nature 1987;326:411-414.
152. Muscat I. Human microsporidiosis. J Infect 1990;21:125-129.
153. Canning EU, Hollister WS. Enterocytozoon bieneusi (microsporidia): prevalence and pathogenicity in AIDS patients. Trans R Soc Trop Med Hyg 1990;84:181-186.
154. Rabeneck L, Gyorkey F, Genta RM, et al. The role of microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann Intern Med 1993;119:895-899.
155. Sandfort J, Hannemann A, Gelderblom H, et al. Enterocytozoon bieneusi infection in an immunocompetent patient who had acute diarrhea and who was not infected with the Human Immunodeficiency Virus. Clin Infect Dis 1994;19: 514-516.
156. Cali A. General microsporidian features and recent findings on AIDS isolates. J Protozool 1991;38:625-630.
157. Schwartz DA, Bryan RT, Weber R, et al. Microsporidiosis in HIV positive patients: current methods for diagnosis using biopsy, cytologic, ultrastructural, immunological, and tissue culture techniques. Folia Parasitol 1994;41:101-109.
158. Orenstien J, Dieterich D, Kotler D. Systemic dissemination of a newly recognized intestinal Microsporidia species in AIDS. AIDS 1992;6:1143-1150.
159. Cello J. AIDS cholangiopathy: spectrum of disease. Ann Intern Med 1986;105:207-210.
160. Pol S, Romana C, Richard S. Microsporidia infection in patients with AIDS and unexplained cholangitis. N Engl J Med 1993;328:95-99.
161. Dore GJ, Marriott DJ, Hing MC, et al. Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the Human Immunodeficiency Virus - response to therapy with albendazole. Clin Infect Dis 1995;21:70-76.
162. Weber R, Bryan R, Owen R, et al. Improved light-microscopical detection of microsporidial spores in stool and duodenal aspirates. N Engl J Med 1992;326:161-166.
163. Didier ES, Orenstein JM, Aldras A, et al. Comparison of three staining methods for detecting microsporidia in fluids. J Clin Microbiol 1995;33:3138-3145.
164. Luna VA, Stewart BK, Bergeron DL, et al. Use of the fluorochrome calcofluor white in the screening of stool specimens for spores of microsporidia. Am J Clin Pathol 1995;103: 656-659.
165. Walzer PD, Judson FN, Murphy KB, et al. Balantidiasis outbreak in Truk. Am J Trop Med Hyg 1973;22:33-41.
166. Lee RV, Prowten AW, Sidney A, et al. Typhlitis due to Balantidium coli in captive lowland gorillas. Rev Infect Dis 1990;12: 1052-1059.
167. Aréan VM, Koppisch E. Balantidiasis: a review and report of cases. Am J Pathol 1956;32:1089-1115.
168. Swartzwelder JC. Balantidiasis. Am J Digest Dis 1950;17: 173-179.
169. Anonymous. Drugs for parasitic infections. The Medical Letter 1995;37:99-108.
170. Yang J, Scholten T. Dientamoeba fragilis: a review noted on its epidemiology, pathogenicity, mode of transmission, and diagnosis. Am J Trop Med Hyg 1977;26:16-22.
171. Spencer MJ, Garcia LS, Chapin MR. Dientamoeba fragilis: an intestinal pathogen in children? Am J Dis Child 1979;133: 390-393.
172. Kean BH, Malloch CL.The neglected ameba: Dientamoeba fragilis: a report of 100 "pure" infections. Am J Digest Dis 1966;11:735-746.
173. Grendon JH, Digiacomo RF, Frost FJ. Descriptive features of Dientamoeba fragilis infections. J Trop Med Hyg 1995;98: 309-315.
174. Zierdt CH. Blastocystis hominis - past and future. Clin Microbiol Rev 1991;4:61-79.
175. Anonymous. Blastocystis hominis: commensal or pathogen? Lancet 1991;337:521-522.
176. Doyle PW, Helgason MM, Mathias RG, et al. Epidemiology and pathogenicity of Blastocystis hominis. J Clin Microbiol 1990;28:116-121.
177. Kain KC, Noble MA, Freeman HJ, et al. Epidemiologic and clinical features associated with Blastocystis hominis infection. Diagn Microbiol Infect Dis 1987;8:235-244.
178. Phillips BP, Zierdt CH. Blastocystis hominis: pathogenic potential in human patients and gnotobiotes. Exp Parasitol 1976;39:358-364.
179. Sheehan DJ, Raucher BG, McKitrick JC. Association of Blastocystis hominis with signs and symptoms of human disease. J Clin Microbiol 1986;24:548-550.
180. Shlim DR, Hoge CW, Rajah R, et al. Is Blastocystis hominis a cause of diarrhea in travelers - a prospective controlled study in Nepal. Clin Infect Dis 1995;21:97-101.
181. Keystone JS. Editorial - Blastocystis hominis and travelers diarrhea. Clin Infect Dis 1995;21:102-103.
182. Sun T, Katz S, Tanenbaum B, et al. Questionable significance of Blastocystis hominis infection. Am J Gastro 1989;84: 1543-1547.
183. Markell EK, Udkow MP. Blastocystis hominis: pathogen or fellow traveler. Am J Trop Med Hyg 1986;35:1023-1026.
184. Miller RA, Minshew BH. Blastocystis hominis: an organism in search of a disease. Rev Infect Dis 1988;10:930-938.
185. Chen J, Vaudry WL, Kowlewska K, et al. Lack of serum immune response to Blastocystis hominis. Lancet 1987;2:1021.